Role of combination of PET-CT and tumor markers in assessment of response in advanced non-small cell lung cancer after chemotherapy and radiotherapy
10.3760/cma.j.issn.1673-422X.2011.06.018
- VernacularTitle:PET-CT联合肿瘤标志物在评价晚期非小细胞肺癌化放疗疗效中的应用
- Author:
Li LIU
;
Huoqiang WANG
- Publication Type:Journal Article
- Keywords:
Tomography,emission-computed;
Tumor markers,biological
- From:
Journal of International Oncology
2011;38(6):453-456
- CountryChina
- Language:Chinese
-
Abstract:
After chemoradiation therapy, tumor tissue metabolism changes earlier than its shape in advanced non-small cell lung cancr (NSCLC). Therefore, Positron emission tomography-computed tomography (PET-CT) can early assess the therapeutic efficacy and prognosis. But PET-CT might bring up some false negative or false positive outcome, while combined with the tumor markers, more accurate assessments of therapeutic efficiency and prognosis could be made for advanced(NSCLC).
